A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS
Abstract Background The transplantation of hematopoietic stem and progenitor cells (HSPCs) or mesenchymal stromal/stem cells (MSCs) for the treatment of a wide variety of diseases has been studied extensively. A challenge with cell-based therapies is that migration to and retention at the target sit...
Saved in:
Main Authors: | Maryke Kahts (Author), Juanita Mellet (Author), Chrisna Durandt (Author), Kinosha Moodley (Author), Beverley Summers (Author), Thomas Ebenhan (Author), Jan Rijn Zeevaart (Author), Omer Aras (Author), Michael S. Pepper (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
by: Maryke Kahts, et al.
Published: (2023) -
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
by: Asif Noor, et al.
Published: (2024) -
89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
by: Albert J. Chang, et al.
Published: (2012) -
Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022) -
Good practices for 89Zr radiopharmaceutical production and quality control
by: Thomas Erik Wuensche, et al.
Published: (2024)